Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq ... Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company ...

Most big pharma companies are now investing in digital ... Talking to journalists at the company’s global headquarters in Basel, Switzerland yesterday, LaPorte spoke enthusiastically about ...

A UK market access summit convened by IQVIA brought together pharma and NHS leaders to ... attention of your UK general manager, but also global headquarters.” The growing role of NHS England ...

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

Stay well-informed and make prudent decisions using our Ratings Table. Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

JOSEPH PREZIOSO / AFP via Getty Images Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration. The drugmaker said the twice-daily pill, Journavx ...

Wall St ends lower as White House says Trump to implement tariffs 1:16 AM UTC The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health ...